News

Clinical Advisor5h
RSV Vaccine mResvia Approved for Adults Aged 18 to 59 at Increased Risk
For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.
RFK Jr.’s firing of little-known committee members could mean families can’t afford vaccines
Robert F. Kennedy Jr. dismissed all members of the CDC’s Advisory Committee on Immunization Practices, which recommends which ...
Can you still trust the US government’s vaccine recommendations?
F or the past 60 years, a committee of independent experts has advised the federal government on vaccine policy, providing ...